Antivirals for pandemic influenza: a triumph of policy over evidence?
Thompson
Matthew
M
Oxford University Department of Primary Health Care, Rosemary Rue Building, Old Road Campus, Headington, Oxford, OX3 7LF, UK. matthew.thompson@dphpc.ox.ac.uk
Heneghan
Carl
C
D000998:Antiviral Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006291:Health Policy; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects*; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D058873:Pandemics
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D009439:Neuraminidase